Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can exercise and a compression sleeve ease Post-Cancer arm swelling?

NCT ID NCT07459881

Symptom relief Sponsor: Far Eastern Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study will test whether combining arm exercises with a pneumatic compression pump can reduce lymphedema (arm swelling) in 20 women who have had breast cancer surgery. Participants will do supervised exercises and then use a compression sleeve for 20 minutes. The researchers will measure arm size, shoulder movement, and quality of life before and after the 12-session program to see if the combination helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Combined upper extremity exercise and pneumatic compression therapy
What this could lead to
If it works, this could offer a simple, non-drug way to manage lymphedema and improve arm function and quality of life for breast cancer survivors.
What could go wrong
This is a very small pilot study with only 20 participants and no comparison group, so results may not be generalizable. The intervention is supportive, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 70 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Female breast cancer patients aged 20-70 years 2. Postoperative unilateral breast cancer surgery with a clinical diagnosis of lymphedema (stage I or II breast cancer treatment, with unilateral lymphedema greater than 2 cm and less than 8 cm at least one measurement point) 3. Completion of subsequent chemotherapy/radiotherapy or other treatments at least 3 months postoperatively 4. Ability to cooperate with 12 treatments and all assessments and sign a consent form Exclusion Criteria: 1. Breast cancer with a tendency for recurrence or metastasis 2. Severe infection of the upper limb (cellulitis) 3. Uncontrolled heart failure, deep vein thrombosis (DVT), severe peripheral vascular disease 4. Stage III lymphedema, bilateral lymphedema, or need to take medications that may affect sweat glands in the upper limbs 5. Other musculoskeletal disorders of the upper limbs, joint deformities, or a history of surgery 6. Pregnancy or other conditions unsuitable for participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer lymphedema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Cancer Lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer lymphedema

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Far Eastern Memorial Hospital

    New Taipei City, Taiwan, 220, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.